Synthetic biology & Biopharma – a unique platform for growth and sustainable future MasterClass

Online MasterClass | 18 & 19 October, 2021

The global synthetic (constructive) biology market is anticipated to reach $30.3 B by 2027 growing at a CAGR of 23.6% during the last 7 years of the investigated period. Private investment in startups is increasing rapidly and added up to over $12 B in the last decade. In 2018, synthetic biology companies raised a total amount of $4.2 B, a two times increase in comparison to the previous year. Synthetic biology finds its inventory applications in several industrial sectors including healthcare, food and agri-tech, tools & services, biomaterials & green chemicals. Its impact on the biopharmaceutical industry is constantly growing enabling novel, better therapies for patients based on gene editing, genetic and metabolic engineering, and computational design, to name a few. To de-risk the target scale operations, platform-based business models are nowadays more frequently leveraged. Emerging technologies trigger the enhancement of sustainable production ways utilizing microbiome fermentation processes, 3D printing, automation, and AI. This masterclass will shed light on various emerging technologies arising from the synthetic/ engineering biology field. Alternative solutions to nowadays challenges, enabling swift development and commercialization of antibodies, bio-therapeutics, precision medicine and accompanying diagnostic tools will be granularly analysed based on cost reduction, innovative business models and impact investment opportunities.

THE EVENT WILL START IN
EVENT INTRODUCTION

The global synthetic (constructive) biology market is anticipated to reach $30.3 B by 2027 growing at a CAGR of 23.6% during the last 7 years of the investigated period. Private investment in startups is increasing rapidly and added up to over $12 B in the last decade. In 2018, synthetic biology companies raised a total amount of $4.2 B, a two times increase in comparison to the previous year. Synthetic biology finds its inventory applications in several industrial sectors including healthcare, food and agri-tech, tools & services, biomaterials & green chemicals. Its impact on the biopharmaceutical industry is constantly growing enabling novel, better therapies for patients based on gene editing, genetic and metabolic engineering, and computational design, to name a few. To de-risk the target scale operations, platform-based business models are nowadays more frequently leveraged. Emerging technologies trigger the enhancement of sustainable production ways utilizing microbiome fermentation processes, 3D printing, automation, and AI. This masterclass will shed light on various emerging technologies arising from the synthetic/ engineering biology field. Alternative solutions to nowadays challenges, enabling swift development and commercialization of antibodies, bio-therapeutics, precision medicine and accompanying diagnostic tools will be granularly analysed based on cost reduction, innovative business models and impact investment opportunities.

Who Should Attend?

• R&D managers, heads and directors • (new) Business developers • Market intelligence managers • Product commercialization managers • Product development strategists • Global innovation leaders • Global partnerships leaders

REQUEST AGENDA FORM
DOWNLOAD THE AGENDA
Request detailed Agenda - Synthetic biology & Biopharma – a unique platform for growth and sustainable future MasterClass
Name
Corporate email
Corporate phone
E-mail consent
Privacy Policy

Past Clients

Testimonials

The level of professionalism of the trainer. Fine-tuned program without wasting time

Managing Director – European pharma company

Testimonials

Clear and interesting way of presenting issues, good examples and very knowledgeable trainer.

HR Director - Multinational company based in Europe

Testimonials

Excellent trainer, super skilled, funny and extremely dynamic

M&A Professional

Testimonials

This training was interesting and I would love to attend more trainings like this.

HR Professional

Testimonials

All lectures of the trainer was exactly what I was looking for and it was directly related to my experties and area that I am working. On top of that he prepared all lectures in a very practical way and also took his time to asnwers to the questions and he made sure that we got the asnwer. The organization of this class was also very good.

Pharmaceutical professional

Testimonials

Comprehensive overview with very knowledgeable and experienced trainers. The break-out sessions were great as they made the course more interactive and allowed us to apply the concepts in practice.

Banking professional from Europe

About GLC EUROPE

Global Leading Conferences is specialized in designing, creating and executing impactful, and pragmatic Conferences, Masterclasses and in-house training.

We take pride in empowering thousands of professionals around the world to learn, network, make connections, and do business with thought leaders and visionaries across multiple industries.

GLC actively collaborates with professionals in major sectors, such as Finance, Pharmaceutical, Human Resources, Health & Safety and Energy to understand the challenges and issues that each industry endures, to be able to construct exclusive and top-tier learning and networking platforms.

Specialized in planning, designing, and organizing interactive, impactful, and pragmatic B2B events, GLC actively collaborates with professionals in major sectors, such as Finance, Pharmaceutical, Human Resources, Health & Safety, and Energy to understand the challenges and issues that each industry endures.

10
years

of constructing industry focused events where business meets intelligence

299
events

where we have been learning to provide a unique experience for our customers

3410
speakers

from top-notch industry establishments proven to make a difference

17761
clients

thereof 96% would attend a GLC event again and would recommend GLC

The MANAGEMENT

GHAZAL ZOHREHNEJAD

Managing Director / Co-founder

LÁSZLÓ ÁRVAI

Managing Director / Co-founder

KRISZTIÁN ÖTVÖS

Managing Director / Co-founder